anmelden
OMX Copenhagen 20
1.544,40
PKT
+5,93
PKT
+0,39
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Copenhagen 20-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.08.18 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.08.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 09.08.18 | Novo Nordisk Neutral | Credit Suisse Group | |
| 09.08.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.08.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 08.08.18 | Novo Nordisk Hold | Commerzbank AG | |
| 08.08.18 | Novo Nordisk buy | UBS AG | |
| 08.08.18 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 08.08.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 08.08.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.08.18 | Novo Nordisk Hold | Commerzbank AG | |
| 25.07.18 | Novo Nordisk buy | UBS AG | |
| 23.07.18 | Novo Nordisk Outperform | Bernstein Research | |
| 19.07.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 16.07.18 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 13.07.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 11.07.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 11.07.18 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 10.07.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 02.07.18 | Novo Nordisk Outperform | Bernstein Research | |
| 28.06.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.06.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 25.06.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 25.06.18 | Novo Nordisk buy | UBS AG | |
| 25.06.18 | Novo Nordisk market-perform | Bernstein Research | |
| 22.06.18 | Novo Nordisk Underweight | Barclays Capital | |
| 22.06.18 | Novo Nordisk Sell | Société Générale Group S.A. (SG) | |
| 22.06.18 | Novo Nordisk Hold | Commerzbank AG | |
| 21.06.18 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 21.06.18 | Novo Nordisk buy | Deutsche Bank AG | |
| 21.06.18 | Novo Nordisk market-perform | Bernstein Research | |
| 21.06.18 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.06.18 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 14.06.18 | Novo Nordisk buy | UBS AG | |
| 12.06.18 | Novo Nordisk market-perform | Bernstein Research | |
| 08.06.18 | Novo Nordisk buy | UBS AG | |
| 31.05.18 | Novo Nordisk Reduce | HSBC | |
| 30.05.18 | Novo Nordisk overweight | Morgan Stanley | |
| 30.05.18 | Novo Nordisk buy | UBS AG | |
| 30.05.18 | Novo Nordisk buy | Deutsche Bank AG |